The problem of aducanumab for the treatment of alzheimer disease

G. Caleb Alexander; Jason Karlawish

doi:10.7326/M21-2603

The problem of aducanumab for the treatment of alzheimer disease

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1303-1304
Number of pages	2
Journal	Annals of internal medicine
Volume	174
Issue number	9
DOIs	https://doi.org/10.7326/M21-2603
State	Published - Sep 1 2021

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/M21-2603

Cite this

@article{f2ce14204bb14fe09c1cd27c26bd50ce,

title = "The problem of aducanumab for the treatment of alzheimer disease",

author = "{Caleb Alexander}, G. and Jason Karlawish",

year = "2021",

month = sep,

day = "1",

doi = "10.7326/M21-2603",

language = "English (US)",

volume = "174",

pages = "1303--1304",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "9",

}

TY - JOUR

T1 - The problem of aducanumab for the treatment of alzheimer disease

AU - Caleb Alexander, G.

AU - Karlawish, Jason

PY - 2021/9/1

Y1 - 2021/9/1

UR - http://www.scopus.com/inward/record.url?scp=85114595591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114595591&partnerID=8YFLogxK

U2 - 10.7326/M21-2603

DO - 10.7326/M21-2603

M3 - Comment/debate

C2 - 34138642

AN - SCOPUS:85114595591

SN - 0003-4819

VL - 174

SP - 1303

EP - 1304

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 9

ER -

The problem of aducanumab for the treatment of alzheimer disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this